| Christopher Paul Slayden, | |
|
1 University Of New Mexico, Msc 10-5610, Albuquerque, NM 87131-0001 | |
| (505) 272-5505 | |
| (505) 272-6399 |
| Full Name | Christopher Paul Slayden |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 12 Years |
| Location | 1 University Of New Mexico, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265798771 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | R6103 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Midland Memorial Hospital | Midland, TX | Hospital |
| Reeves County Hospital District | Pecos, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Texas Urology Pa | 1557317781 | 3 |
News Archive
Researchers at the University of Alabama at Birmingham have shown -; for the first time -; that established lung fibrosis can be reversed using a drug treatment that targets cell metabolism.
Vanguard Health Systems, Inc. ("Vanguard") announced today that in connection with the previously announced tender offers and consent solicitations (the "Tender Offers" and "Consent Solicitations") by Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Health Holding Company I, LLC ("VHS Holdco I"), the extended early tender period in respect of each of the Tender Offers expired at 5:00 p.m., New York City time, on January 29, 2010 (the "New Consent Payment Deadline").
Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
CURE Media Group, the nation's leading digital and print media enterprise focused on cancer patients and survivors of cancer, welcomes CancerCare to its Strategic Alliance Partnership Program.
› Verified 4 days ago
| Entity Name | West Texas Urology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467453860 PECOS PAC ID: 1557317781 Enrollment ID: O20050330000658 |
News Archive
Researchers at the University of Alabama at Birmingham have shown -; for the first time -; that established lung fibrosis can be reversed using a drug treatment that targets cell metabolism.
Vanguard Health Systems, Inc. ("Vanguard") announced today that in connection with the previously announced tender offers and consent solicitations (the "Tender Offers" and "Consent Solicitations") by Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Health Holding Company I, LLC ("VHS Holdco I"), the extended early tender period in respect of each of the Tender Offers expired at 5:00 p.m., New York City time, on January 29, 2010 (the "New Consent Payment Deadline").
Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
CURE Media Group, the nation's leading digital and print media enterprise focused on cancer patients and survivors of cancer, welcomes CancerCare to its Strategic Alliance Partnership Program.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christopher Paul Slayden, 2706 W Cuthbert Ave, Ste C, Midland, TX 79701-3887 Ph: (432) 687-0311 | Christopher Paul Slayden, 1 University Of New Mexico, Msc 10-5610, Albuquerque, NM 87131-0001 Ph: (505) 272-5505 |
News Archive
Researchers at the University of Alabama at Birmingham have shown -; for the first time -; that established lung fibrosis can be reversed using a drug treatment that targets cell metabolism.
Vanguard Health Systems, Inc. ("Vanguard") announced today that in connection with the previously announced tender offers and consent solicitations (the "Tender Offers" and "Consent Solicitations") by Vanguard Health Holding Company II, LLC ("VHS Holdco II") and Vanguard Health Holding Company I, LLC ("VHS Holdco I"), the extended early tender period in respect of each of the Tender Offers expired at 5:00 p.m., New York City time, on January 29, 2010 (the "New Consent Payment Deadline").
Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
CURE Media Group, the nation's leading digital and print media enterprise focused on cancer patients and survivors of cancer, welcomes CancerCare to its Strategic Alliance Partnership Program.
› Verified 4 days ago
Laura Anne Mihalko, M.D. Urology Medicare: Medicare Enrolled Practice Location: Msc 10 5610, University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-5505 Fax: 505-272-6399 | |
Dr. Matthew D Katz, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-925-7759 Fax: 505-272-4156 | |
Dr. Frances Maria Alba, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1 University Of New Mexico, Dept. Of Surgery. Msc10-5610, Albuquerque, NM 87131 Phone: 505-272-5505 | |
Donald Lee Kettwich, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 711 Encino Pl Ne, Suite E, Albuquerque, NM 87102 Phone: 505-245-5737 Fax: 505-245-5739 | |
Dr. Peter Abraham Headley, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 610 Broadway Blvd Ne, Albuquerque, NM 87102 Phone: 505-242-3991 Fax: 505-243-8405 | |
Dr. Damara Lee Kaplan, PHD, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4901 Lang Ave Ne, Albuquerque, NM 87109 Phone: 505-842-8171 Fax: 505-246-0684 | |
Jessica Megan Chen Ming, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1004 Columbia Dr Ne, Albuquerque, NM 87106 Phone: 617-645-0313 |